The Leadership Team at IM Therapeutics drives the strategic vision and operational execution of the company's HLA-directed therapeutic platform. Comprising experts in scientific research and medical practice, including co-founders and executives, the team collaborates to advance innovative therapies for autoimmune diseases, ensuring alignment between research initiatives and clinical development. Their collective leadership fosters an environment of scientific excellence and facilitates partnerships that propel the company’s growth and impact in the field of type 1 diabetes and beyond.
View all